Long-term Efficacy and Safety Study of GV-971
NCT05181475
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
800
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
Sodium Oligomannate Capsules (GV-971)
Sponsor
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.